Cell and Gene Therapy (CGT) emerged as a potential treatment for blood-based cancers via the FDA’s accelerated approval process. However, CGT was quickly reined in even as it heralded a wave of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback